Jane Street Group LLC Reduces Holdings in Teleflex Incorporated (NYSE:TFX)

Jane Street Group LLC lessened its holdings in Teleflex Incorporated (NYSE:TFX) by 25.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 15,473 shares of the medical technology company’s stock after selling 5,350 shares during the period. Jane Street Group LLC’s holdings in Teleflex were worth $3,827,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of TFX. Cromwell Holdings LLC raised its position in shares of Teleflex by 59.0% during the 3rd quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock worth $33,000 after purchasing an additional 49 shares during the last quarter. Avior Wealth Management LLC increased its position in Teleflex by 190.6% during the third quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock worth $38,000 after buying an additional 101 shares in the last quarter. Ashton Thomas Securities LLC acquired a new position in shares of Teleflex in the third quarter worth $40,000. True Wealth Design LLC lifted its position in shares of Teleflex by 16,600.0% in the third quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock valued at $41,000 after acquiring an additional 166 shares in the last quarter. Finally, Canada Pension Plan Investment Board acquired a new stake in shares of Teleflex during the second quarter valued at $42,000. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

TFX stock opened at $172.66 on Thursday. The company has a market cap of $8.02 billion, a PE ratio of 34.33, a price-to-earnings-growth ratio of 1.84 and a beta of 1.16. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The stock has a 50-day moving average price of $204.80 and a two-hundred day moving average price of $219.97. Teleflex Incorporated has a 12-month low of $172.45 and a 12-month high of $256.85.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.38 by $0.11. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business had revenue of $764.40 million during the quarter, compared to analysts’ expectations of $768.68 million. During the same quarter in the previous year, the business earned $3.64 EPS. The company’s revenue for the quarter was up 2.4% on a year-over-year basis. As a group, research analysts predict that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, December 16th. Shareholders of record on Friday, November 15th were paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.79%. The ex-dividend date was Friday, November 15th. Teleflex’s dividend payout ratio is presently 27.04%.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research note on Monday. StockNews.com raised shares of Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Royal Bank of Canada lowered their target price on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. Mizuho reduced their price target on Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, November 1st. Finally, Truist Financial lowered their price objective on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research report on Wednesday. Three equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $255.14.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.